Skip to main content
. 2012 Jun 1;55(9):2501–2512. doi: 10.1007/s00125-012-2590-5

Fig. 1.

Fig. 1

Circulating EPC levels are reduced in type 2 diabetes. (a) Representative FACS plots and gating profile set on the basis of the isotype control sample as used for the quantification of CD34+ cells and CD34+KDR+ cells. (b) CD34+ cell levels were 1.3-fold lower in type 2 diabetic patients compared with healthy controls. (c) In patients with type 2 diabetes, similar levels of circulating CD34+ cells were observed in patients with and without MVD. (d) In non-diabetic individuals with MVD the total number of CD34+ cells was similar to that in healthy controls. (e) CD34+KDR+ cell levels were 1.7-fold lower in type 2 diabetic patients compared with healthy controls. (f) In type 2 diabetes, similar levels of circulating CD34+KDR+ cells were observed in patients with and without MVD. (g) In non-diabetic individuals with MVD the number of CD34+KDR+ cells was significantly reduced compared with healthy controls. Data are expressed as mean values ± SEM; *p < 0.05. T2DM, type 2 diabetes mellitus